Safety and efficacy of ONO-4578 plus nivolumab in metastatic colorectal cancer.

Authors

null

Akihito Kawazoe

Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan

Akihito Kawazoe , Atsuo Takashima , Hiroshi Matsuoka , Yasuo Hamamoto , Tatsuya Okuno , Tetsuya Hamaguchi , Kensei Yamaguchi , Eiji Oki , Naotoshi Sugimoto , Yasushi Tsuji , Shogen Boku , Tomohiro Nishina

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

jRCT2080223441

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 93)

DOI

10.1200/JCO.2024.42.3_suppl.93

Abstract #

93

Poster Bd #

F16

Abstract Disclosures

Similar Posters